Oxidative stress, placental ageing-related pathologies and adverse pregnancy outcomes

American Journal of Reproductive Immunology

Volumn 77, Issue 5, 2017, Pages

  Sultana, Zakia ^a,b   Maiti, Kaushik ^a,b   Aitken, John ^b   Morris, Jonathan ^c   Dedman, Lee ^b   Smith, Roger ^a,b  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

intrauterine growth restriction; oxidative stress; placental ageing; pre eclampsia; preterm birth; senescence; stillbirth

Indexed keywords

ADVERSE OUTCOME; AGING; APOPTOSIS; CELL AGING; CELL FUNCTION; FETUS WASTAGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLACENTA; PLACENTA DISORDER; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; STILLBIRTH; TROPHOBLAST; ANIMAL; FEMALE; PATHOLOGY; PHYSIOLOGY; PREGNANCY;

AGING; ANIMALS; FEMALE; HUMANS; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 85013920734     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12653     Document Type: Review

References (115)

1. Londero AP, Orsaria M, Marzinotto S, et al. Placental aging and oxidation damage in a tissue micro-array model: an immunohistochemistry study. Histochem Cell Biol. 2016;146:191–204.
2. Rosso P. Placenta as an aging organ. Curr Concepts Nutr. 1976;4:23–41.
3. Gude NM, Roberts CT, Kalionis B, King RG. Growth and function of the normal human placenta. Thromb Res. 2004;114:397–407.
4. Jirásek JE. The Embryo: Blastogenesis, Differentiation of the Inner Cell Mass and Formation of Germ Layers. In: Keith LG, ed. An Atlas of the Human Embryo and Fetus: a photographic review of human prenatal development. New York: Parthenon Publishing; 2000:27.
5. James JL, Carter AM, Chamley LW. Human placentation from nidation to 5 weeks of gestation. Part I: What do we know about formative placental development following implantation? Placenta. 2012;33:327–334.
6. Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol. 2000;92:35–43.
7. te Velde EA, Exalto N, Hesseling P, van der Linden HC. First trimester development of human chorionic villous vascularization studied with CD34 immunohistochemistry. Hum Reprod. 1997;12:1577–1581.
8. Ahmed A, Perkins J. Angiogenesis and intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol. 2000;14:981–998.
9. Boyd JD, Hamilton WJ. The Human Placenta. Cambridge: W. Heffer & Sons; 1970. p.
10. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol. 1992;80:283–285.
11. Jauniaux E, Gulbis B, Burton GJ. The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus - a review. Placenta. 2003;24:S86–S93.
12. Jauniaux E, Greenwold N, Hempstock J, Burton GJ. Comparison of ultrasonographic and Doppler mapping of the intervillous circulation in normal and abnormal early pregnancies. Fertil Steril. 2003;79:100–106.
13. Lim K-H, Zhou Y, Janatpour M, et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol. 1997;151:1809–1818.
14. Jaffe R, Jauniaux E, Hustin J. Maternal circulation in the first-trimester human placenta - myth or reality? Am J Obstet Gynecol. 1997;176:695–705.
15. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol. 2000;157:2111–2122.
16. Smith SC, Baker PN. Placental apoptosis is increased in post-term pregnancies. Br J Obstet Gynaecol. 1999;106:861–862.
17. Smith SC, Baker PN, Symonds EM. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol. 1997;177:57–65.
18. Scifres CM, Nelson DM. Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol. 2009;587:3453–3458.
19. Levy R, Smith SD, Chandler K, Sadovsky Y, Nelson DM. Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol. 2000;278:C982–C988.
20. Heazell A, Lacey H, Jones C, Huppertz B, Baker P, Crocker I. Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast. Placenta. 2008;29:175–186.
21. Soleymanlou N, Wu Y, Wang JX, et al. A novel Mtd splice isoform is responsible for trophoblast cell death in pre-eclampsia. Cell Death Differ. 2005;12:441–452.
22. Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res. 2002;90:1274–1281.
23. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol. 2002;186:158–166.
24. Levy R, Smith SD, Yusuf K, et al. Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol. 2002;186:1056–1061.
25. Huppertz B. Placental villous trophoblast: the altered balance between proliferation and apoptosis triggers pre-eclampsia. J Reprod Med Endocrinol. 2006;3:103–108.
26. Kadyrov M, Schmitz C, Black S, Kaufmann P, Huppertz B. Pre-eclampsia and maternal anaemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. Placenta. 2003;24:540–548.
27. Fedarko NS. The biology of aging and frailty. Clin Geriatr Med. 2011;27:27–37.
28. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005;6:611–622.
29. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458–460.
30. Elks CE, Scott RA. The Long and Short of Telomere Length and Diabetes. Diabetes. 2014;63:65–67.
31. Saretzki G, Von Zglinicki T. Replicative aging, telomeres, and oxidative stress. Ann N Y Acad Sci. 2002;959:24–29.
32. Aviv A. The Epidemiology of Human Telomeres: Faults and Promises. J Gerontol A Biol Sci Med Sci. 2008;63:979–983.
33. von Zglinicki T, Saretzki G, Döcke W, Lotze C. Mild Hyperoxia Shortens Telomeres and Inhibits Proliferation of Fibroblasts: A Model for Senescence? Exp Cell Res. 1995;220:186–193.
34. Allsopp RC, Harley CB. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res. 1995;219:130–136.
35. Bonney EA, Krebs K, Saade G, et al. Differential senescence in feto-maternal tissues during mouse pregnancy. Placenta. 2016;43:26–34.
36. Raffetto JD, Leverkus M, Park H-Y, Menzoian JO. Synopsis on cellular senescence and apoptosis. J Vasc Surg. 2001;34:173–177.
37. Burton DGA. Cellular senescence, ageing and disease. Age. 2009;31:1–9.
38. Sukenik-Halevy R, Amiel A, Kidron D, Liberman M, Ganor-Paz Y, Biron-Shental T. Telomere homeostasis in trophoblasts and in cord blood cells from pregnancies complicated with preeclampsia. Am J Obstet Gynecol 2016;214:283. e281-283.e287.
39. Lombard DB, Schwer B, Alt FW, Mostoslavsky R. SIRT6 in DNA repair, metabolism and ageing. J Intern Med. 2008;263:128–141.
40. Greider CW. Telomeres, telomerase and senescence. BioEssays. 1990;12:363–369.
41. Biron-Shental T, Sukenik-Halevy R, Sharon Y, et al. Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2010;202:e381–e387.
42. Smith R, Maiti K, Aitken R. Unexplained antepartum stillbirth: a consequence of placental aging? Placenta. 2013;34:310–313.
43. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27:339–344.
44. Houben JM, Moonen HJ, van Schooten FJ, Hageman GJ. Telomere length assessment: biomarker of chronic oxidative stress? Free Radic Biol Med. 2008;44:235–246.
45. Nicholls C, Li H, Wang JQ, Liu JP. Molecular regulation of telomerase activity in aging. Protein Cell. 2011;2:726–738.
46. Burton GJ, Jauniaux E. Oxidative Stress. Best Pract Res Clin Obstet Gynaecol. 2011;25:287–299.
47. Kurlak LO, Green A, Loughna P, Broughton Pipkin F. Oxidative stress markers in hypertensive states of pregnancy: preterm and term disease. Front Physiol 2014;5:310.
48. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300.
49. Lagouge M, Larsson NG. The role of mitochondrial DNA mutations and free radicals in disease and ageing. J Intern Med. 2013;273:529–543.
50. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A. 1996;93:11848–11852.
51. Gambino V, De Michele G, Venezia O, et al. Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging. Aging Cell. 2013;12:435–445.
52. Mistry HD, Williams PJ. The Importance of Antioxidant Micronutrients in Pregnancy. Oxid Med Cell Longev. 2011;2011:841749.
53. Wisdom SJ, Wilson R, McKillop JH, Walker JJ. Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol. 1991;165:1701–1704.
54. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004;122:369–382.
55. Wang Y, Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta. 1998;19:581–586.
56. Wang YP, Walsh SW, Guo JD, Zhang JY. Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol. 1991;165:1690–1694.
57. Sbrana E, Suter MA, Abramovici AR, et al. Maternal tobacco use is associated with increased markers of oxidative stress in the placenta. Am J Obstet Gynecol. 2011;205:e241–e247.
58. Menon R, Fortunato SJ, Yu J, et al. Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. Placenta. 2011;32:317–322.
59. Ashfaq M, Janjua MZ, Nawaz M. Effects of maternal smoking on placental morphology. J Ayub Med Coll Abbottabad. 2003;15:12–15.
60. Romero R, Dey SK, Fisher SJ. Preterm Labor: One Syndrome, Many Causes. Science. 2014;345:760–765.
61. Haddad R, Tromp G, Kuivaniemi H, et al. Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol 2006;195:394. e391-324.
62. Phillippe M. Cell-Free Fetal DNA, Telomeres, and the Spontaneous Onset of Parturition. Reprod Sci. 2015;22:1186–1201.
63. Menon R, Behnia F, Polettini J, Saade GR, Campisi J, Velarde M. Placental membrane aging and HMGB1 signaling associated with human parturition. Aging. 2016;8:216–230.
64. Polettini J, Behnia F, Taylor BD, Saade GR, Taylor RN, Menon R. Telomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition? PLoS ONE. 2015;10:e0137188.
65. Polettini J, Dutta EH, Behnia F, Saade GR, Torloni MR, Menon R. Aging of intrauterine tissues in spontaneous preterm birth and preterm premature rupture of the membranes: a systematic review of the literature. Placenta. 2015;36:969–973.
66. Menon R. Oxidative stress damage as a detrimental factor in preterm birth pathology. Front Immunol. 2014;5:567.
67. Menon R, Boldogh I, Hawkins HK, et al. Histological evidence of oxidative stress and premature senescence in preterm premature rupture of the human fetal membranes recapitulated in vitro. Am J Pathol. 2014;184:1740–1751.
68. Romero R, Kusanovic JP, Chaiworapongsa T, Hassan SS. Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae. Best Pract Res Clin Obstet Gynaecol. 2011;25:313–327.
69. Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10:49.
70. Cinkaya A, Keskin HL, Buyukkagnici U, et al. Maternal plasma total antioxidant status in preterm labor. J Obstet Gynaecol Res. 2010;36:1185–1188.
71. Ahamed M, Mehrotra PK, Kumar P, Siddiqui MKJ. Placental lead-induced oxidative stress and preterm delivery. Environ Toxicol Pharmacol. 2009;27:70–74.
72. Mustafa MD, Pathak R, Ahmed T, et al. Association of glutathione S-transferase M1 and T1 gene polymorphisms and oxidative stress markers in preterm labor. Clin Biochem. 2010;43:1124–1128.
73. Rayman MP, Wijnen H, Vader H, Kooistra L, Pop V. Maternal selenium status during early gestation and risk for preterm birth. CMAJ. 2011;183:549–555.
74. Than NG, Romero R, Tarca AL, et al. Mitochondrial manganese superoxide dismutase mRNA expression in human chorioamniotic membranes and its association with labor, inflammation, and infection. J Matern Fetal Neonatal Med. 2009;22:1000–1013.
75. Brodsky D, Christou H. Current concepts in intrauterine growth restriction. J Intensive Care Med. 2004;19:307–319.
76. Frøen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand. 2004;83:801–807.
77. Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011;377:1331–1340.
78. Chan PYL, Morris JM, Leslie GI, Kelly PJ, Gallery EDM. The long-term effects of prematurity and intrauterine growth restriction on cardiovascular, renal, and metabolic function. Int J Pediatr. 2010;2010:280402.
79. Yung H-W, Calabrese S, Hynx D, et al. Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am J Pathol. 2008;173:451–462.
80. Krishna U, Bhalerao S. Placental Insufficiency and Fetal Growth Restriction. J Obstet Gynaecol India. 2011;61:505–511.
81. Mandò C, De Palma C, Stampalija T, et al. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia. Am J Physiol Endocrinol Metab. 2014;306:E404–E413.
82. Huppertz B. Placental origins of preeclampsia challenging the current hypothesis. Hypertension. 2008;51:970–975.
83. Biri A, Bozkurt N, Turp A, Kavutcu M, Himmetoglu Ö, Durak İ. Role of oxidative stress in intrauterine growth restriction. Gynecol Obstet Invest. 2007;64:187–192.
84. Takagi Y, Nikaido T, Toki T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch. 2004;444:49–55.
85. Fujimaki A, Watanabe K, Mori T, Kimura C, Shinohara K, Wakatsuki A. Placental oxidative DNA damage and its repair in preeclamptic women with fetal growth restriction. Placenta. 2011;32:367–372.
86. Kimura C, Watanabe K, Iwasaki A, et al. The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction. J Matern Fetal Neonatal Med. 2013;26:491–496.
87. Sahlin L, Ostlund E, Wang H, Holmgren A, Fried G. Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with pre-eclampsia and intrauterine growth restriction. Placenta. 2000;21:603–609.
88. Davy P, Nagata M, Bullard P, Fogelson NS, Allsopp R. Fetal growth restriction is associated with accelerated telomere shortening and increased expression of cell senescence markers in the placenta. Placenta. 2009;30:539–542.
89. Kudo T, Izutsu T, Sato T. Telomerase activity and apoptosis as indicators of ageing in placenta with and without intrauterine growth retardation. Placenta. 2000;21:493–500.
90. Kim S-Y, Lee S-P, Lee J-S, Yoon S-J, Jun G, Hwang Y-J. Telomerase and Apoptosis in the Placental Trophoblasts of Growth Discordant Twins. Yonsei Med J. 2006;47:698–705.
91. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–1594.
92. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785–799.
93. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 2013;209:544. e541-544 e512.
94. Rajakumar A, Cerdeira AS, Rana S, et al. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension. 2012;59:256–264.
95. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200–1204.
96. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, McLaughlin MK. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol. 1989;161:1025–1034.
97. Hubel CA. Oxidative Stress in the Pathogenesis of Preeclampsia. Exp Biol Med. 1999;222:222–235.
98. Trudinger BJ, Giles WB, Cook CM, Bombardieri J, Collins L. Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance. Br J Obstet Gynaecol. 1985;92:23–30.
99. Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol. 2000;156:321–331.
100. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 2009;30(Suppl A):S43–S48.
101. Redman CW. Current topic: pre-eclampsia and the placenta. Placenta. 1991;12:301–308.
102. Poston L, Igosheva N, Mistry HD, et al. Role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am J Clin Nutr. 2011;94:1980S–1985S.
103. Madazli R, Benian A, Aydin S, Uzun H, Tolun N. The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia. J Obstet Gynaecol. 2002;22:477–480.
104. Kaur G, Mishra S, Sehgal A, Prasad R. Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem. 2008;313:37–44.
105. Wang Y, Walsh SW. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta. 2001;22:206–212.
106. Sahay AS, Sundrani DP, Wagh GN, Mehendale SS, Joshi SR. Regional differences in the placental levels of oxidative stress markers in pre-eclampsia. Int J Gynaecol Obstet. 2015;129:213–218.
107. Morikawa S, Kurauchi O, Tanaka M, et al. Increased mitochondrial damage by lipid peroxidation in trophoblast cells of preeclamptic placentas. Biochem Mol Biol Int. 1997;41:767–775.
108. Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig. 1996;3:179–184.
109. Watson A, Palmer M, Jauniaux E, Burton G. Evidence for oxygen-derived free radical mediated damage to first trimester human trophoblast in vitro. Placenta. 1998;19:259–276.
110. Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig. 2004;11:342–352.
111. Stacey T, Thompson JM, Mitchell EA, Ekeroma AJ, Zuccollo JM, McCowan LM. The Auckland Stillbirth study, a case-control study exploring modifiable risk factors for third trimester stillbirth: methods and rationale. Aust N Z J Obstet Gynaecol. 2011;51:3–8.
112. Sutan R, Campbell D, Prescott GJ, Smith WC. The risk factors for unexplained antepartum stillbirths in Scotland, 1994 to 2003. J Perinatol. 2010;30:311–318.
113. Ferrari F, Facchinetti F, Saade G, Menon R. Placental telomere shortening in stillbirth: a sign of premature senescence? J Matern Fetal Neonatal Med. 2016;29:1283–1288.
114. Smith GC, Yu CK, Papageorghiou AT, Cacho AM, Nicolaides KH. Maternal uterine artery Doppler flow velocimetry and the risk of stillbirth. Obstet Gynecol. 2007;109:144–151.
115. Pinar H, Goldenberg RL, Koch MA, et al. Placental Findings in Singleton Stillbirths. Obstet Gynecol. 2014;123:325–336.